Our results provide, for the first time, evidence of NOVA2 expression and upregulation in tumor ECs and highlight hypoxia as a potential regulatory factor. These findings open a completely new perspective to study tumor vasculature and to uncover NOVA2 as a potential source of biomarkers and therapeutic targets based on AS isoforms.
No takes yet. Share an insight, caveat, or question.
Gallo et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: